FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| PQ Pharmacy LLC | 81375-610 | 81375-610-03 | Tirzepatide | Tirzepatide | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| PQ Pharmacy LLC | 81375-610 | 81375-610-01 | Tirzepatide | Tirzepatide | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| PQ Pharmacy LLC | 81375-610 | 81375-610-02 | Tirzepatide | Tirzepatide | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| PQ Pharmacy LLC | 81375-202 | 81375-202-10 | Tropicamide/Phenylephrine Sterile Ophthalmic Solution | Tropicamide1.0%/Phenylephrine2.5% | 10 mg/1 mL; 25 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| PQ Pharmacy LLC | 81375-202 | 81375-202-05 | Tropicamide/Phenylephrine Sterile Ophthalmic Solution | Tropicamide1.0%/Phenylephrine2.5% | 10 mg/1 mL; 25 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| ProRx | 118230111 | Semaglutide | 12.5 mg/5 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Semaglutide | 7.5 mg/3 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Semaglutide | 5 mg/2 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Semaglutide | 1 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Semaglutide | 2.5 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Semaglutide | 8 mg/3.2 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Semaglutide | 6 mg/2.4 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Semaglutide | 10 mg/4 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Semaglutide | 20 mg/4 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Sermorelin | 15 mg/6 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Tirzepatide | 60 mg/3 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Tirzepatide | 40 mg/2 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Tirzepatide | 20 mg/2 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Tirzepatide | 30 mg/3 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Tirzepatide | 50 mg/2.5 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Tirzepatide | 10 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Glutathione | 2000 mg/10 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Glutathione | 6000 mg/30 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Gonadorelin | 2 mg/10 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Liraglutide | 36 mg/6 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Nadide | 1200 mg/6 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Nadide | 1000 mg/10 mL | 2025-1 | source_no_ndc | 2026-10-27 | |||
| ProRx | 118230111 | Naltrexone | 1.5 mg/1.5 mg | 2025-1 | source_no_ndc | 2026-10-27 | |||
| Qualgen LLC | 034474862 | 69761-252 | 69761-252-01 | Testosterone | 25 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-372 | 69761-372-01 | Testosterone | 37.5 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-122 | 69761-122-01 | Testosterone | 12.5 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-102 | 69761-102-01 | Testosterone | 100 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-203 | 69761-203-01 | Testosterone | 200 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-502 | 69761-502-01 | Testosterone | 50 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-872 | 69761-872-01 | Testosterone | 87.5 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-202 | 69761-202-01 | Testosterone | 200 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-103 | 69761-103-01 | Testosterone | 100 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-503 | 69761-503-01 | Testosterone | 50 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-873 | 69761-873-01 | Testosterone | 87.5 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-101 | 69761-101-01 | Estradiol | 10 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-151 | 69761-151-01 | Estradiol | 15 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-201 | 69761-201-01 | Estradiol | 20 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-061 | 69761-061-01 | Estradiol | 6 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-251 | 69761-251-01 | Estradiol | 25 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-121 | 69761-121-01 | Estradiol | 12.5 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-181 | 69761-181-01 | Estradiol | 18 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 034474862 | 69761-212 | 69761-212-01 | Anastrozole; Testosterone | 20 mg; 200 mg | 2025-1 | valid | 2026-10-27 | |
| Qualgen LLC | 69761-061 | 69761-061-01 | Estradiol | Estradiol | 6 mg | 2025-1 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-151 | 69761-151-01 | Estradiol / Stearic Acid | Estradiol | 15 mg | 2025-1 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-201 | 69761-201-01 | Estradiol / Stearic Acid | Estradiol | 20 mg | 2025-1 | valid | 2026-09-18 |